Published in Women's Health Weekly, October 5th, 2006
According to recent research published in the journal Breast Cancer Research and Treatment, "Detection of metachronous contralateral breast cancer (MCBC) is an important aspect of follow-up among the many women previously diagnosed with first primary breast cancer (FPBC). While randomized studies have demonstrated the efficacy of early detection of FPBC, such findings cannot be generalized to women previously diagnosed with breast cancer since they were specifically excluded from participation."
"In this study, we determined if detection of MCBC at stage...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly